Trial intelligence / Profile preview

Rosiglitazone in Adolescents With Type 1 Diabetes

NCT00372086Phase 4Completed

Sponsor
University of New South Wales
Start
Aug 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of rosiglitazone in type 1 diabetes mellitus (T1D), sponsored by University of New South Wales. Started Aug 2003; status: completed.

02

Drugs

rosiglitazone
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT00372086.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00372086.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call